Nouvelle déclaration d'incident
No de la demande: 2008-4155
Numéro de référence du titulaire d'homologation: PROSAR Case 1-16543008
Nom du titulaire (nom légal complet, aucune abbréviation): The Hartz Mountain Company
Adresse: 400 Plaza Drive
Ville: Secaucus
État: New Jersey
Pays: USA
Code postal /Zip: 07094-3688
Incident chez un animal domestique
Pays: UNITED STATES
État: NORTH CAROLINA
ARLA No d'homologation ARLA No de la demande d'homologation EPA No d'homologation. 2596-79
Nom du produit: UltraGuard Flea and Tick Powder for Dogs
Poudre
Oui
Inconnu
Site: Animal / Usage sur un animal domestique
Non
Propriétaire de l'animal
Cat / Chat
Domestic Shorthair
1
Femme
13
14
lbs
Cutanée
Unknown / Inconnu
>24 hrs <=3 days / >24 h <=3 jours
Système
Persisted until death
Oui
Oui
2
Day(s) / Jour(s)
Mort
Treatment / Traitement
(p.ex. description des symptômes tels que la fréquence et la gravité
1-16543008: The reporter called on 08/19/2008 to report the accidental exposure of a 13 year-old cat to a topical flea and tick powder intended for canines containing the active ingredient Tetrachlorvinphos on 08/15/2008. Immediately after product application the reporter realized her mistake and thoroughly washed the cat in an oatmeal shampoo for pets. The cat was asymptomatic and the caller contacted her veterinarian who advised that the cat be brought into the clinic for treatment and observation. The cat did not develop symptoms while at the veterinary clinic overnight and at the time of the report the caller was unsure whether the cat had received IV fluids. The cat was discharged from the veterinary clinic on 08/16/2008 with oral antibiotics. The cat remained asymptomatic until 08/17/2008 when the cat developed respiratory distress and was taken to the veterinary college for treatment. A thoracic radiograph showed pneumonia and pulmonary edema. The cat developed congestive heart failure later in the day on 08/17/2008 and was treated with IV fluids and oxygen. The cat went into cardiac arrest and was resuscitated twice before arresting a third time and dying. The treating DVM at the veterinary college advised the reporter that the product was unrelated to the cat¿s signs and death. The caller was advised on 08/18/2008 that the product¿s active ingredient could be expected to cause signs related to salivation, lacrimation, urination, diarrhea, and vomiting if it had not been washed off the cat. The signs seen on 08/17/2008 were not consistent with product exposure. A recommendation was made to speak with her primary DVM and the treating DVM at the veterinary college to get further information about the actual diagnosis.
Mort